StemBioSys CEO: Company has room to grow in San Antonio

Bob Hutchens is CEO of StemBioSys Inc. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey – Senior ...

SA researchers exploring use of re-purposed cancer drugs to combat deadly TB

Texas Biomedical Research Institute President and CEO Dr. Larry Schlesinger, right, with Eusondia Arnett, ...

InCube Labs awarded $10M subcontract
May 25, 2016


San Antonio Express-News

InCube Labs of San Antonio has been awarded a $10 million subcontract to work with the University of Pittsburgh on developing an implant that could improve or restore bladder function in patients who have suffered spinal cord injuries.

The funds awarded to InCube are part of a U.S. Department of Defense contract to the University of Pittsburgh. The amount of the university’s overall contract hasn’t been publicly disclosed.

InCube, a life sciences research and development outfit, will work toward securing an investigational device exemption from the U.S. Food and Drug Administration to allow the implant to be used in clinical trials to test its safety and whether it is effective for patients. Changfeng Tai, a University of Pittsburgh associate professor of urology, is the lead investigator on the Department of Defense project.

“We are delighted to have the opportunity to work with Pitt to solve this incredibly important clinical problem,” said InCube Chairman and CEO Mir Imran.

InCube relocated to San Antonio from San Jose, California, in exchange for $10 million in combined incentive grants awarded in 2010. Those incentive grants came from the city of San Antonio, which invested $6 million; Bexar County, $2 million; the Texas Research and Technology Foundation, $1 million; and the University of Texas at San Antonio and the UT Health Science Center, which each contributed $500,000.

Stay informed. Subscribe to BioMed SA news alerts.